Thomas Tscherning

Frigoscandia AB offers national and international transport and warehousing services. The firm provides thermally-regulated logistics services. It engages in shipping and storage of fresh, chilled and frozen goods from the producer to the Nordic area and the rest of the world. The company was founded in 1948 and is headquartered in Helsingborg, Sweden.

Halda AB is the biggest traffic management and payment administration company for the taxi business in Scandinavia. It offers the market's most comprehensive product range, including products with the well-known Trancometer® and Halda® brands. Halda's roots go back to 1985, when the original company was established. In 1999 it was acquired by Trancometer System AB. Halda works with information technology and has extensive expertise in three interacting key areas: Vehicle equipment, electronics and software Communications Computers, networks and software Halda integrates the various areas of technology and supplies complete concept solutions. Halda's development department works with a network of subcontractors. These are specialist companies in their fields, vehicle electronics or radio technology for instance. This gives Halda great flexibility when developing new products and systems. Because the subcontractors take part in the development work, high quality of the individual products is guaranteed, as well as optimum cost-effectiveness of the entire system solution.

BI Technology A/S (BI-T) is a venture capital firm founded in 1969. The firm is headquartered in Copenhagen, Denmark.

F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom.

Nereus Pharmaceuticals, Inc. is a drug discovery and development company pursuing untapped sources of chemical diversity through identifying drug candidates derived from marine microbes. Nereus' discovery portfolio also includes additional drug candidates for oncology, inflammation, and infectious diseases. The company was founded in 1998 and is headquartered in San Diego, CA.

Warren Pharmaceuticals, Inc. develops tissue-protective technologies. The company was founded by Anthony Cerami and Michael Brines on May 17, 2001 and is headquartered in Tarrytown, NY.

Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark.